Our previous study reported TP53 and RB1 co-alteration in two G3 pancreatic NEN with a history of prior low-grade NET though the corresponding low-grade NETs were not evaluated in this study to prove clonality [14]. This evidence concerns the gene TP53 and pancreatic neuroendocrine neoplasm.